Literature DB >> 34073112

Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Features of Tumor Invasion and Down-Regulates C-Myc Expression in a Mouse Model of Colorectal Cancer Liver Metastasis.

Georgina E Riddiough1,2, Theodora Fifis1, Katrina A Walsh1, Vijayaragavan Muralidharan1, Christopher Christophi1, Bang M Tran2, Elizabeth Vincan2,3,4, Marcos V Perini1.   

Abstract

(1) Background: Recent clinical and experimental data suggests that the liver's regenerative response following partial hepatectomy can stimulate tumor recurrence in the liver remnant. The Wnt/β-catenin pathway plays important roles in both colorectal cancer carcinogenesis and liver regeneration. Studies have shown that the Wnt/β-catenin pathway regulates multiple renin-angiotensin system (RAS) genes, whilst RAS inhibition (RASi) reduces tumor burden and progression. This study explores whether RASi attenuates features of tumor progression in the regenerating liver post-hepatectomy by modulating Wnt/β-catenin signaling. (2)
Methods: Male CBA mice underwent CRLM induction, followed one week later by 70% partial hepatectomy. Mice were treated daily with captopril, a RASi, at 250 mg/kg/day or vehicle control from experimental Day 4. Tumor and liver samples were analyzed for RAS and Wnt signaling markers using qRT-PCR and immunohistochemistry. (3)
Results: Treatment with captopril reduced the expression of down-stream Wnt target genes, including a significant reduction in both c-myc and cyclin-D1, despite activating Wnt signaling. This was a tumor-specific response that was not elicited in corresponding liver samples. (4) Conclusions: We report for the first time decreased c-myc expression in colorectal tumors following RASi treatment in vivo. Decreased c-myc expression was accompanied by an attenuated invasive phenotype, despite increased Wnt signaling.

Entities:  

Keywords:  Wnt pathway; c-myc; colorectal liver metastasis; liver regeneration; renin-angiotensin system

Year:  2021        PMID: 34073112     DOI: 10.3390/cancers13112734

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  52 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

2.  Liver regeneration stimulates tumor metastases.

Authors:  Nadia Harun; Mehrdad Nikfarjam; Vijayaragavan Muralidharan; Christopher Christophi
Journal:  J Surg Res       Date:  2007-01-24       Impact factor: 2.192

3.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

4.  Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration.

Authors:  S P Monga; P Pediaditakis; K Mule; D B Stolz; G K Michalopoulos
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

5.  Wnt signaling controls the phosphorylation status of beta-catenin.

Authors:  Mascha van Noort; Jan Meeldijk; Ruurd van der Zee; Olivier Destree; Hans Clevers
Journal:  J Biol Chem       Date:  2002-02-07       Impact factor: 5.157

6.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

7.  Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

Authors:  T Brabletz; A Jung; K Hermann; K Günther; W Hohenberger; T Kirchner
Journal:  Pathol Res Pract       Date:  1998       Impact factor: 3.250

8.  Frizzled-7 as a potential therapeutic target in colorectal cancer.

Authors:  Koji Ueno; Mikako Hiura; Yutaka Suehiro; Shoichi Hazama; Hiroshi Hirata; Masaaki Oka; Kohzoh Imai; Rajvir Dahiya; Yuji Hinoda
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

Review 9.  Wnt/β-catenin signaling and renin-angiotensin system in chronic kidney disease.

Authors:  Lili Zhou; Youhua Liu
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-03       Impact factor: 2.894

Review 10.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.

Authors:  Roel Nusse; Hans Clevers
Journal:  Cell       Date:  2017-06-01       Impact factor: 41.582

View more
  2 in total

1.  Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Tumour Progression in the Regenerating Liver Following Partial Hepatectomy.

Authors:  Georgina E Riddiough; Katrina A Walsh; Theodora Fifis; Georgios Kastrappis; Bang M Tran; Elizabeth Vincan; Vijayaragavan Muralidharan; Christopher Christophi; Claire L Gordon; Marcos V Perini
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

2.  Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia.

Authors:  Hao Zhou; Wei Liu; Yongming Zhou; Zhenya Hong; Jian Ni; Xiaoping Zhang; Ziping Li; Mengyuan Li; Wenjuan He; Donghua Zhang; Xuexing Chen; Jianhua Zhu
Journal:  J Exp Clin Cancer Res       Date:  2021-11-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.